Exploration of Combinational Therapeutic Strategies for HCC Based on TCGA HCC Database

Yan, D; Li, CX; Zhou, YT; Yan, X; Zhi, WH; Qian, HL; Han, Y

Han, Y (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Dept Intervent Therapy, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China.;Qian, HL (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Clin Res Ctr Canc, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China.

ONCOLOGIE, 2022; 24 (1): 101

Abstract

Hepatocellular carcinoma (HCC) is one of the most deadly types of cancer. Sorafenib is currently the only available first-line molecular targeted drug......

Full Text Link